Yahoo Web Search

Search results

1. • Adopting a Wellness Mindset: Kidney Conversations with Dr. Vincent Anthony - Part 3 - Los Angeles...

     Los Angeles Sentinel· 2 days ago

     LAS: How does one discover whether or not he or she has chronic kidney disease? DVA: When you talk about chronic kidney disease ...

2. • The National Kidney Foundation's 2024 Spring Clinical Meetings Late-Breaking Presentation on New...

     FOX 4 Kansas City· 3 days ago

     IgAN is an incurable glomerular disease that can cause chronic kidney disease (CKD) and is a leading cause of end-stage</ ...

3. • 

     Study identifies factors associated with hydroxychloroquine retinopathy

     Medical Xpress· 3 days ago

     Factors associated with an increased risk for hydroxychloroquine retinopathy have been identified...

4. • 

     Man who received first genetically modified pig kidney transplant dies

     NJ.com· 4 days ago

     Richard “Rick” Slayman, the world’s first person to receive a genetically modified pig kidney...

5. • 

     First human to receive transplanted pig kidney dies

     Reuters· 3 days ago

     A man with end-stage renal disease who earlier this year became the first human to receive a new kidney from a genetically modified pig ...

6. • ... Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting -...

     Benzinga· 2 days ago

     OLC is a next-generation lanthanum-based phosphate binding agent utilizing proprietary nanoparticle technology being developed for the treatment of hyperphosphatemia in patients with chronic ...

7. • 

     Fact Check Team: Study finds majority of Americans at risk of a heart condition

     FOX 11 Green Bay· 3 days ago

     A new study published in the Journal of the American Medical Association found that a majority of...

8. • ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International...

     Benzinga· 3 days ago

     ZVSA or "ZyVersa"))), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory...2024 BIO International ...

9. • 

     BridgeBio's Acoramidis shows promise in heart disease study By Investing.com

     Investing.com· 4 days ago

     Additionally, among the 21 participants with Stage 4 chronic kidney disease (CKD), treatment with...

10. • 

      Earnings call: Renalytix reports Q3 results, optimistic on KidneyIntelX By Investing.com

      Investing.com· 1 day ago

      Renalytix, a healthcare company specializing in kidney disease diagnostics, discussed its...